돌아가기
Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
HRID 1373533생성일: 2026년 10월 26일

Sodium triacetoxyborohydride → 7-{4-[4-(5-Chloro-2-isopropoxy-phenyl)-piperazin-1-yl]-butoxy}-3,4-dihydro-1H-[1,8]naphthyridin-2-one

https://huagongshe.com/reaction/1373533

반응식

참여 물질

역할이름HCID투입량
반응물Sodium triacetoxyborohydrideHCID 5049666—
반응물1-(5-Chloro-2-isopropoxy-phenyl)-piperazineHCID 21073166—
반응물4-((7-Oxo-5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)oxy)butanalHCID 21073377—
용매1,1-DichloroethaneHCID 6365—
용매Ethyl AcetateHCID 8857—
생성물7-{4-[4-(5-Chloro-2-isopropoxy-phenyl)-piperazin-1-yl]-butoxy}-3,4-dihydro-1H-[1,8]naphthyridin-2-oneHCID 2107371145.4%

반응 단계

To a suspension of 4-(7-oxo-5,6,7,8-tetrahydro-[1,8]naphthyridin-2-yloxy)-butyraldehyde (0.241 g, 1.02 mmol, 1 eq) and 1-(5-chloro-2-isopropoxy-phenyl)-piperazine (0.382 g, 1.13 mmol, 1.1 eq) in dichloroethane (5 mL) was added NaBH(OAc)3 (0.583 g, 2.75 mmol, 2.67 eq). The slurry was allowed to stir overnight at room temperature (18 h). Analysis by HPLC showed reaction mostly complete. The mixture was diluted with EtOAc and quenched with saturated NaHCO3. The organic phase was then washed with brine, dried over Na2SO4, filtered and evaporated in vacuo. Purification by silica gel chromatography (100% EtOAc) followed by formation of the HCl salt using 1N HCl in ether provided the title compound (0.219 g, 25%). MS: APCI: M+1: 473.2 (Exact Mass: 472.22).

출처 및 근거

DOI10.6084/m9.figshare.5104873.v1
특허 번호US07160888B2
출처 데이터셋uspto-grants-2007_01
ORD IDord-dd37439ed99643c7a02d08a9e358a307
출처 메모uspto-grants-2007_01